The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive value of MAOB gene expression for targeted therapy in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB (Alliance)/SWOG 80405.
 
Wu Zhang
No Relationships to Disclose
 
Joshua Millstein
No Relationships to Disclose
 
Yan Yang
No Relationships to Disclose
 
Fang-Shu Ou
Consulting or Advisory Role - SC Liver Research Consortium
 
Federico Innocenti
Employment - Abbvie
Stock and Other Ownership Interests - AbbVie
Honoraria - Tempus
Consulting or Advisory Role - Emerald Lake Safety; Symberix
Patents, Royalties, Other Intellectual Property - United States Patent: "Flavopiridol drug combinations and methods with reduced side effects", Ratain MJ, Innocenti F, Iyer L. Filed on April 12, 2001, serial number 09/835,082.; United States Patent: “Methods of identifying risk of bevacizumab-induced proteinuria and hypertension”, Innocenti F, Quintanilha J, Lin D, Owzar K, Wang J. Filed on July 17, 2020, serial number 16/932,002.; United States Patent: “Optimization of cancer treatment with irinotecan”, Ratain MJ, Innocenti F, Karabatsos P, Grimsley C, Di Rienzo A. Filed on February 12, 2003, serial number 60/446,942.; United States Provisional Patent Application: “Plasma Levels of Angiopoietin-2, VEGF-A, And VCAM-1 as Markers of Bevacizumab Induced Hypertension”, Innocenti F, Quintanilha J. Filed on April 1, 2021, serial number 63/169,301.
Travel, Accommodations, Expenses - Abbvie
 
Hiroyuki Arai
No Relationships to Disclose
 
Shivani Soni
No Relationships to Disclose
 
Shannon M. Mumenthaler
No Relationships to Disclose
 
Sandra Algaze
No Relationships to Disclose
 
Priya Jayachandran
No Relationships to Disclose
 
Monica M. Bertagnolli
Leadership - Leap Therapeutics; Natera
Stock and Other Ownership Interests - Grupo Oncoclinicas; Leap Therapeutics; Natera
Research Funding - Abbvie (Inst); Agenus (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Baxalta (Inst); Bayer (Inst); Bayer Health (Inst); Breast Cancer Research Foundation (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Chinese Medical Education Association (Inst); Clovis Oncology (Inst); Complion (Inst); Eisai (Inst); EMD Serono (Inst); Exelixis (Inst); Genentech (Inst); GHI Pharma (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); GlycoMimetics (Inst); Incyte (Inst); Janssen (Inst); Jazz Pharmaceuticals (Inst); Kazia Therapeutics (Inst); Leidos (Inst); Leidos (Inst); Lexicon (Inst); Lilly (Inst); Massachusetts General Hospital (Inst); Matrex (Inst); Mayo Clinic (Inst); Merck (Inst); Merck (Inst); Millenium Pharamceuticals (Inst); MITRE Corporation (Inst); Novartis (Inst); Patient-Centered Outcomes Research Institute (PCORI) (Inst); Pfizer (Inst); Pharmacyclics (Inst); Robert Wood Johnson Foundation (Inst); Sagerock Advisors (Inst); Sanofi (Inst); Seagen (Inst); SERVIER (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tesaro (Inst); Teva (Inst)
(OPTIONAL) Uncompensated Relationships - Leap Therapeutics; Natera
 
Dustin A. Deming
Consulting or Advisory Role - Array BioPharma; Bayer; Lilly; Pfizer; Promega
Research Funding - Bayer; Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Millennium (Inst); Revolution Medicines (Inst)
 
Donna Niedzwiecki
No Relationships to Disclose
 
Richard M. Goldberg
Stock and Other Ownership Interests - Advanced Chemotherapy Technologies
Consulting or Advisory Role - Adaptimmune; AstraZeneca; Bayer; Compass Therapeutics; Eisai/H3 Biomedicine; G1 Therapeutics; GlaxoSmithKline; IQvia; Merck; Sorrento Therapeutics; Taiho Pharmaceutical; UpToDate
Expert Testimony - Genentech/Roche; Taiho Pharmaceutical
 
Robert J. Mayer
Consulting or Advisory Role - Bayer
 
Charles David Blanke
No Relationships to Disclose
 
Alan P. Venook
Consulting or Advisory Role - Amgen; BridgeBio Pharma; Exelixis; GlaxoSmithKline; Merck Sharp & Dohme
Research Funding - Amgen
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
 
Omar Kabbarah
Employment - ORIC Pharmaceuticals; Zai Lab
Stock and Other Ownership Interests - ORIC Pharmaceuticals; Zai Lab
Research Funding - ORIC Pharmaceuticals; Zai Lab
Travel, Accommodations, Expenses - ORIC Pharmaceuticals; Zai Lab
 
Francesca Battaglin
Travel, Accommodations, Expenses - Caris Life Sciences
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Fulgent Genetics; G1 THerapeutics; GlaxoSmithKline; Isofol Medical; Jazz Pharmaceuticals; Merck Serono; Oncocyte; Roche
Consulting or Advisory Role - Bayer; BMS; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; BMS; Merck Serono